vs
Side-by-side financial comparison of LIVEPERSON INC (LPSN) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $59.3M, roughly 1.2× LIVEPERSON INC). Viridian Therapeutics, Inc.\DE runs the higher net margin — -49.0% vs -77.8%, a 28.7% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -19.0%). LIVEPERSON INC produced more free cash flow last quarter ($-12.0M vs $-84.7M).
LivePerson is a global technology company that develops conversational commerce and AI software.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
LPSN vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $59.3M | $70.6M |
| Net Profit | $-46.1M | $-34.6M |
| Gross Margin | 73.2% | — |
| Operating Margin | -68.7% | -56.7% |
| Net Margin | -77.8% | -49.0% |
| Revenue YoY | -19.0% | 81958.1% |
| Net Profit YoY | 58.9% | 54.9% |
| EPS (diluted) | $-9.22 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $59.3M | — | ||
| Q3 25 | $60.2M | $70.6M | ||
| Q2 25 | $59.6M | — | ||
| Q1 25 | $64.7M | — | ||
| Q4 24 | $73.2M | — | ||
| Q3 24 | $74.2M | — | ||
| Q2 24 | $79.9M | — | ||
| Q1 24 | $85.1M | — |
| Q4 25 | $-46.1M | — | ||
| Q3 25 | $8.7M | $-34.6M | ||
| Q2 25 | $-15.7M | — | ||
| Q1 25 | $-14.1M | — | ||
| Q4 24 | $-112.1M | — | ||
| Q3 24 | $-28.3M | — | ||
| Q2 24 | $41.8M | — | ||
| Q1 24 | $-35.6M | — |
| Q4 25 | 73.2% | — | ||
| Q3 25 | 71.4% | — | ||
| Q2 25 | 69.7% | — | ||
| Q1 25 | 71.8% | — | ||
| Q4 24 | 77.4% | — | ||
| Q3 24 | 73.1% | — | ||
| Q2 24 | 79.4% | — | ||
| Q1 24 | 71.3% | — |
| Q4 25 | -68.7% | — | ||
| Q3 25 | -24.2% | -56.7% | ||
| Q2 25 | -10.8% | — | ||
| Q1 25 | -26.2% | — | ||
| Q4 24 | -138.0% | — | ||
| Q3 24 | -21.6% | — | ||
| Q2 24 | -37.3% | — | ||
| Q1 24 | -42.7% | — |
| Q4 25 | -77.8% | — | ||
| Q3 25 | 14.5% | -49.0% | ||
| Q2 25 | -26.4% | — | ||
| Q1 25 | -21.8% | — | ||
| Q4 24 | -153.2% | — | ||
| Q3 24 | -38.1% | — | ||
| Q2 24 | 52.3% | — | ||
| Q1 24 | -41.8% | — |
| Q4 25 | $-9.22 | — | ||
| Q3 25 | $-2.76 | — | ||
| Q2 25 | $-0.17 | — | ||
| Q1 25 | $-0.24 | — | ||
| Q4 24 | $-17.23 | — | ||
| Q3 24 | $-4.74 | — | ||
| Q2 24 | $-0.33 | — | ||
| Q1 24 | $-0.40 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $95.0M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-44.5M | $503.0M |
| Total Assets | $454.7M | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $95.0M | — | ||
| Q3 25 | $106.7M | $490.9M | ||
| Q2 25 | $162.0M | — | ||
| Q1 25 | $176.3M | — | ||
| Q4 24 | $183.2M | — | ||
| Q3 24 | $142.1M | — | ||
| Q2 24 | $146.0M | — | ||
| Q1 24 | $127.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $512.1M | — |
| Q4 25 | $-44.5M | — | ||
| Q3 25 | $-22.1M | $503.0M | ||
| Q2 25 | $-82.4M | — | ||
| Q1 25 | $-74.9M | — | ||
| Q4 24 | $-67.3M | — | ||
| Q3 24 | $45.9M | — | ||
| Q2 24 | $66.6M | — | ||
| Q1 24 | $19.2M | — |
| Q4 25 | $454.7M | — | ||
| Q3 25 | $511.4M | $577.1M | ||
| Q2 25 | $604.2M | — | ||
| Q1 25 | $596.2M | — | ||
| Q4 24 | $607.8M | — | ||
| Q3 24 | $692.0M | — | ||
| Q2 24 | $703.8M | — | ||
| Q1 24 | $724.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 26.69× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-9.7M | $-84.6M |
| Free Cash FlowOCF − Capex | $-12.0M | $-84.7M |
| FCF MarginFCF / Revenue | -20.2% | -120.1% |
| Capex IntensityCapex / Revenue | 3.9% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-42.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-9.7M | — | ||
| Q3 25 | $-6.0M | $-84.6M | ||
| Q2 25 | $-11.7M | — | ||
| Q1 25 | $-3.1M | — | ||
| Q4 24 | $-3.1M | — | ||
| Q3 24 | $4.8M | — | ||
| Q2 24 | $-17.9M | — | ||
| Q1 24 | $1.1M | — |
| Q4 25 | $-12.0M | — | ||
| Q3 25 | $-8.9M | $-84.7M | ||
| Q2 25 | $-14.8M | — | ||
| Q1 25 | $-6.9M | — | ||
| Q4 24 | $-6.8M | — | ||
| Q3 24 | $-230.0K | — | ||
| Q2 24 | $-22.9M | — | ||
| Q1 24 | $-10.4M | — |
| Q4 25 | -20.2% | — | ||
| Q3 25 | -14.8% | -120.1% | ||
| Q2 25 | -24.9% | — | ||
| Q1 25 | -10.6% | — | ||
| Q4 24 | -9.2% | — | ||
| Q3 24 | -0.3% | — | ||
| Q2 24 | -28.7% | — | ||
| Q1 24 | -12.2% | — |
| Q4 25 | 3.9% | — | ||
| Q3 25 | 4.8% | 0.2% | ||
| Q2 25 | 5.3% | — | ||
| Q1 25 | 5.8% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 6.2% | — | ||
| Q1 24 | 13.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | -0.69× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.43× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LPSN
| Hosted Services Business | $51.0M | 86% |
| Professional Services | $8.3M | 14% |
VRDN
Segment breakdown not available.
